‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
The Beacon
Can We Effectively Target FGFR with the Novel Agent Erdafitinib for Muscle-Invasive Bladder Cancer? Highlights from ASCO 2018 (BMIC-050)
30
00:00:00
/ 00:02:59
30